Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis

Beatrice Grabner, Daniel Schramek, Kristina M. Mueller, Herwig P. Moll, Jasmin Svinka, Thomas Hoffmann, Eva Bauer, Leander Blaas, Natascha Hruschka, Katalin Zboray, Patricia Stiedl, Harini Nivarthi, Edith Bogner, Wolfgang Gruber, Thomas Mohr, Ralf Harun Zwick, Lukas Kenner, Valeria Poli, Fritz Aberger, Dagmar StoiberGerda Egger, Harald Esterbauer, Johannes Zuber, Richard Moriggl, Robert Eferl, B. Györffy, Josef M. Penninger, Helmut Popper, Emilio Casanova

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

STAT3 is considered to play an oncogenic role in several malignancies including lung cancer; consequently, targeting STAT3 is currently proposed as therapeutic intervention. Here we demonstrate that STAT3 plays an unexpected tumour-suppressive role in KRAS mutant lung adenocarcinoma (AC). Indeed, lung tissue-specific inactivation of Stat3 in mice results in increased Kras G12D -driven AC initiation and malignant progression leading to markedly reduced survival. Knockdown of STAT3 in xenografted human AC cells increases tumour growth. Clinically, low STAT3 expression levels correlate with poor survival and advanced malignancy in human lung AC patients with smoking history, which are prone to KRAS mutations. Consistently, KRAS mutant lung tumours exhibit reduced STAT3 levels. Mechanistically, we demonstrate that STAT3 controls NF-κB-induced IL-8 expression by sequestering NF-κB within the cytoplasm, thereby inhibiting IL-8-mediated myeloid tumour infiltration and tumour vascularization and hence tumour progression. These results elucidate a novel STAT3-NF-κB-IL-8 axis in KRAS mutant AC with therapeutic and prognostic relevance.

Original languageEnglish
Article number6285
JournalNature Communications
Volume6
DOIs
Publication statusPublished - Mar 4 2015

Fingerprint

lungs
Tumors
Carcinogenesis
tumors
Lung
Interleukin-8
Neoplasms
progressions
Adenocarcinoma
cytoplasm
infiltration
mutations
Infiltration
deactivation
mice
Survival
cancer
histories
Tissue
Lung Neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., ... Casanova, E. (2015). Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications, 6, [6285]. https://doi.org/10.1038/ncomms7285

Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. / Grabner, Beatrice; Schramek, Daniel; Mueller, Kristina M.; Moll, Herwig P.; Svinka, Jasmin; Hoffmann, Thomas; Bauer, Eva; Blaas, Leander; Hruschka, Natascha; Zboray, Katalin; Stiedl, Patricia; Nivarthi, Harini; Bogner, Edith; Gruber, Wolfgang; Mohr, Thomas; Zwick, Ralf Harun; Kenner, Lukas; Poli, Valeria; Aberger, Fritz; Stoiber, Dagmar; Egger, Gerda; Esterbauer, Harald; Zuber, Johannes; Moriggl, Richard; Eferl, Robert; Györffy, B.; Penninger, Josef M.; Popper, Helmut; Casanova, Emilio.

In: Nature Communications, Vol. 6, 6285, 04.03.2015.

Research output: Contribution to journalArticle

Grabner, B, Schramek, D, Mueller, KM, Moll, HP, Svinka, J, Hoffmann, T, Bauer, E, Blaas, L, Hruschka, N, Zboray, K, Stiedl, P, Nivarthi, H, Bogner, E, Gruber, W, Mohr, T, Zwick, RH, Kenner, L, Poli, V, Aberger, F, Stoiber, D, Egger, G, Esterbauer, H, Zuber, J, Moriggl, R, Eferl, R, Györffy, B, Penninger, JM, Popper, H & Casanova, E 2015, 'Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis', Nature Communications, vol. 6, 6285. https://doi.org/10.1038/ncomms7285
Grabner B, Schramek D, Mueller KM, Moll HP, Svinka J, Hoffmann T et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nature Communications. 2015 Mar 4;6. 6285. https://doi.org/10.1038/ncomms7285
Grabner, Beatrice ; Schramek, Daniel ; Mueller, Kristina M. ; Moll, Herwig P. ; Svinka, Jasmin ; Hoffmann, Thomas ; Bauer, Eva ; Blaas, Leander ; Hruschka, Natascha ; Zboray, Katalin ; Stiedl, Patricia ; Nivarthi, Harini ; Bogner, Edith ; Gruber, Wolfgang ; Mohr, Thomas ; Zwick, Ralf Harun ; Kenner, Lukas ; Poli, Valeria ; Aberger, Fritz ; Stoiber, Dagmar ; Egger, Gerda ; Esterbauer, Harald ; Zuber, Johannes ; Moriggl, Richard ; Eferl, Robert ; Györffy, B. ; Penninger, Josef M. ; Popper, Helmut ; Casanova, Emilio. / Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. In: Nature Communications. 2015 ; Vol. 6.
@article{122a10b6310d49daba6ffad750ea7d7f,
title = "Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis",
abstract = "STAT3 is considered to play an oncogenic role in several malignancies including lung cancer; consequently, targeting STAT3 is currently proposed as therapeutic intervention. Here we demonstrate that STAT3 plays an unexpected tumour-suppressive role in KRAS mutant lung adenocarcinoma (AC). Indeed, lung tissue-specific inactivation of Stat3 in mice results in increased Kras G12D -driven AC initiation and malignant progression leading to markedly reduced survival. Knockdown of STAT3 in xenografted human AC cells increases tumour growth. Clinically, low STAT3 expression levels correlate with poor survival and advanced malignancy in human lung AC patients with smoking history, which are prone to KRAS mutations. Consistently, KRAS mutant lung tumours exhibit reduced STAT3 levels. Mechanistically, we demonstrate that STAT3 controls NF-κB-induced IL-8 expression by sequestering NF-κB within the cytoplasm, thereby inhibiting IL-8-mediated myeloid tumour infiltration and tumour vascularization and hence tumour progression. These results elucidate a novel STAT3-NF-κB-IL-8 axis in KRAS mutant AC with therapeutic and prognostic relevance.",
author = "Beatrice Grabner and Daniel Schramek and Mueller, {Kristina M.} and Moll, {Herwig P.} and Jasmin Svinka and Thomas Hoffmann and Eva Bauer and Leander Blaas and Natascha Hruschka and Katalin Zboray and Patricia Stiedl and Harini Nivarthi and Edith Bogner and Wolfgang Gruber and Thomas Mohr and Zwick, {Ralf Harun} and Lukas Kenner and Valeria Poli and Fritz Aberger and Dagmar Stoiber and Gerda Egger and Harald Esterbauer and Johannes Zuber and Richard Moriggl and Robert Eferl and B. Gy{\"o}rffy and Penninger, {Josef M.} and Helmut Popper and Emilio Casanova",
year = "2015",
month = "3",
day = "4",
doi = "10.1038/ncomms7285",
language = "English",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis

AU - Grabner, Beatrice

AU - Schramek, Daniel

AU - Mueller, Kristina M.

AU - Moll, Herwig P.

AU - Svinka, Jasmin

AU - Hoffmann, Thomas

AU - Bauer, Eva

AU - Blaas, Leander

AU - Hruschka, Natascha

AU - Zboray, Katalin

AU - Stiedl, Patricia

AU - Nivarthi, Harini

AU - Bogner, Edith

AU - Gruber, Wolfgang

AU - Mohr, Thomas

AU - Zwick, Ralf Harun

AU - Kenner, Lukas

AU - Poli, Valeria

AU - Aberger, Fritz

AU - Stoiber, Dagmar

AU - Egger, Gerda

AU - Esterbauer, Harald

AU - Zuber, Johannes

AU - Moriggl, Richard

AU - Eferl, Robert

AU - Györffy, B.

AU - Penninger, Josef M.

AU - Popper, Helmut

AU - Casanova, Emilio

PY - 2015/3/4

Y1 - 2015/3/4

N2 - STAT3 is considered to play an oncogenic role in several malignancies including lung cancer; consequently, targeting STAT3 is currently proposed as therapeutic intervention. Here we demonstrate that STAT3 plays an unexpected tumour-suppressive role in KRAS mutant lung adenocarcinoma (AC). Indeed, lung tissue-specific inactivation of Stat3 in mice results in increased Kras G12D -driven AC initiation and malignant progression leading to markedly reduced survival. Knockdown of STAT3 in xenografted human AC cells increases tumour growth. Clinically, low STAT3 expression levels correlate with poor survival and advanced malignancy in human lung AC patients with smoking history, which are prone to KRAS mutations. Consistently, KRAS mutant lung tumours exhibit reduced STAT3 levels. Mechanistically, we demonstrate that STAT3 controls NF-κB-induced IL-8 expression by sequestering NF-κB within the cytoplasm, thereby inhibiting IL-8-mediated myeloid tumour infiltration and tumour vascularization and hence tumour progression. These results elucidate a novel STAT3-NF-κB-IL-8 axis in KRAS mutant AC with therapeutic and prognostic relevance.

AB - STAT3 is considered to play an oncogenic role in several malignancies including lung cancer; consequently, targeting STAT3 is currently proposed as therapeutic intervention. Here we demonstrate that STAT3 plays an unexpected tumour-suppressive role in KRAS mutant lung adenocarcinoma (AC). Indeed, lung tissue-specific inactivation of Stat3 in mice results in increased Kras G12D -driven AC initiation and malignant progression leading to markedly reduced survival. Knockdown of STAT3 in xenografted human AC cells increases tumour growth. Clinically, low STAT3 expression levels correlate with poor survival and advanced malignancy in human lung AC patients with smoking history, which are prone to KRAS mutations. Consistently, KRAS mutant lung tumours exhibit reduced STAT3 levels. Mechanistically, we demonstrate that STAT3 controls NF-κB-induced IL-8 expression by sequestering NF-κB within the cytoplasm, thereby inhibiting IL-8-mediated myeloid tumour infiltration and tumour vascularization and hence tumour progression. These results elucidate a novel STAT3-NF-κB-IL-8 axis in KRAS mutant AC with therapeutic and prognostic relevance.

UR - http://www.scopus.com/inward/record.url?scp=84924185168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924185168&partnerID=8YFLogxK

U2 - 10.1038/ncomms7285

DO - 10.1038/ncomms7285

M3 - Article

C2 - 25734337

AN - SCOPUS:84924185168

VL - 6

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 6285

ER -